Skip to content

Repeated autologous bone marrow transfusion through portal vein for treating decompensated liver cirrhosis after splenectomy: a controlled clinical trial

Repeatedly autologous bone marrow transplantation via portal vein administration for the treatment of decompensated liver cirrhosis: a controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-17012592
Enrollment
Unknown
Registered
2017-09-05
Start date
2014-11-01
Completion date
Unknown
Last updated
2017-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

decompensated liver cirrhosis

Interventions

intraportal autologous bone marrow transfusion:intraportal autologous bone marrow transfusion

Sponsors

Shanghai Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients attended the Shanghai Public Health Clinical Center, China, were diagnosed with decompensated liver cirrhosis caused by chronic hepatitis B, hepatitis C, or alcoholic cirrhosis and autoimmune liver cirrhosis. Patients required splenectomy because of portal hypertension or hypersplenism and met all the following inclusion criteria: aged 20–70 years, decompensated liver cirrhosis, abnormal serum albumin (ALB) and/or bilirubin and/or prothrombin time, and no viable hepatocellular carcinoma seen on a computed tomography (CT) scan.

Exclusion criteria

Exclusion criteria: The exclusion criteria were evidence of extrahepatic biliary diseases, severe cardiac insufficiency, and no severe diseases such as stroke or myocardial infarction in the last 6 months.

Design outcomes

Primary

MeasureTime frame
alanine aminotransferase;serum albumin;total bilirubin;prothrombin activity;Cholinesterase;liver stiffness measurement;

Secondary

MeasureTime frame
a-fetoprotein;

Contacts

Public ContactBaochi Liu

Shanghai Public Health Clinical Center

liubaochi@shaphc.org+86 18916056626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026